MedTrace Logo

Clinical Dementia Rating Medical Record

NCT04763941 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 144

Last updated 2022-05-02

No results posted yet for this study

Summary

The assessment of severity of the cognitive and functional impairment is essential in the follow-up of patients with neurocognitive disorders and in the assessment of the effectiveness of therapeutics. However, the systematic assessment of the Clinical Dementia Rating (CDR) scale is limited due to the time required to complete it (approximately 45 min to 1 hour). Insofar as studies have shown correspondences between the CDR and scales measuring cognitive and neuropsychological performance, and as part of memory consultations, several functional and neuropsychological scales are systematically administered, we wish to conduct a study validating the feasibility of the CDR based on information already available in the patient's file compared to the evaluation of the CDR by the usual method (face-to-face interview in consultation).

This study should highlight the feasibility of scoring the CDR-SB from the files of patients in memory consultation, first in terms of reliability of the scores obtained compared to the standard evaluation, and on the other hand in terms of organization and duration of administration.

Conditions

  • Clinical Dementia Rating (CDR) From the Analysis of Medical Record
  • Clinical Dementia Rating (CDR) Face-to-face Interview With the Patient

Interventions

DIAGNOSTIC_TEST

CDR assessment face-to-face

The assessment of the CDR is administered once by a psychologist with the patient and his caregiver.

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Principal Investigators

  • Anthony Bathsavanis, Psy D · Hôpital des Charpennes

  • Pierre Krolak-Salmon, MD · Hopital Edouard Herriot

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2020-10-01
Completion
2022-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04763941 on ClinicalTrials.gov